Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 Years' experience

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 2, 2009, Pages 160-165

  Lee, Chun Yi ^a   Chen, Po Yen ^a,b   Huang, Fang Liang ^a   Lin, Chen Fu ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Bacterial; Cross infection; Drug resistance; Intensive care units; Pediatric

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; METICILLIN; OXACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDIASIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LOWER RESPIRATORY TRACT INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; NONHUMAN; PEDIATRIC HOSPITAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; CROSS INFECTION; HUMANS; INCIDENCE; INTENSIVE CARE UNITS, PEDIATRIC; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 67651108810     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Foglia EE, Fraser VJ, Elward AM. Effect of nosocomial infections due to antibiotic-resistant organisms on length of stay and mortality in the pediatric intensive care unit. Infect Control Hosp Epidemiol. 2007;28:299-306.
2. Urrea M, Pons M, Serra M, Latorre C, Palomeque A. Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr Infect Dis J. 2003;22:490-494 (Pubitemid 36782186)
3. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, Sohn AH, Levine GL, Siegel JD, et al; Pediatric Prevention Network. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr. 2002;140:432-438
4. Stover BH, Shulman ST, Bratcher DF, Brady MT, Levine GL, Jarvis WR; Pediatric Prevention Network. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control. 2001;29:152-157
5. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol. 2000;21:260-263
6. Binkley S, Fishman NO, LaRosa LA, Marr AM, Nachamkin I, Wordell D, et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol. 2006;27:682-687 (Pubitemid 44271948)
7. Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr; Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project; National Nosocomial Infections Surveillance (NNIS) System Hospitals. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis. 2001;33:324-330
8. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. Pediatrics. 1999;103:39-45.
9. Von Dolinger de Brito D, de Almeida Silva H, Jose Oliveira E, Arantes A, Abdallah VO, Tannus Jorge M, et al. Effect of neonatal intensive care unit environment on the incidence of hospital-acquired infection in neonates. J Hosp Infect. 2007;65:314-318 (Pubitemid 46477982)
10. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J. 2003;22:686-691 (Pubitemid 36999643)
11. Horan TC, Culver DH, Jarvis WR, Emori G, Banerjee S, Martone W. Pathogens causing nosocomial infections: preliminary data from the National Nosocomial Infections Surveillance system. Antimicrob Newslett. 1988;5:65-67
12. Frank M, Gur E, Givon-Lavi N, Peled N, Dagan R, Leibovitz E. Nosocomial bloodstream infections in children and adolescents in southern Israel: a 10-year prospective study (1992-2001). Scand J Infect Dis. 2005;37:177-183
13. Hsueh PR, Liu YC, Yang D, Yan JJ, Wu TL, Huang WK, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan. Microb Drug Resist. 2001;7:373-382
14. McDonald LC, Lauderdale TL, Shiau YR, Chen PC, Lai JF, Wang HY, et al; TSAR Participating Hospitals. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int J Antimicrob Agents. 2004;23:362-370
15. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob. 2006;5:2.
16. Gonzalez BE, Rueda AM, Shelburne SA 3rd, Musher DM, Hamill RJ, Hulten KG. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol. 2006;27:1051-1056
17. Zaoutis TE, Toltzis P, Chu J, Abrams T, Dul M, Kim J, et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J. 2006;25:343-348
18. Hsueh PR, Liu CY, Luh KT. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis. 2002;8:132-137 (Pubitemid 34202434)
19. Lauderdale TL, McDonald LC, Shiau YR, Chen PC, Wang HY, Lai JF, et al; TSAR Participating Hospitals. The status of antimicrobial resistance in Taiwan among Gram-negative pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program, 2000. Diagn Microbiol Infect Dis. 2004;48:211-219
20. Wu CJ, Lee HC, Lee NY, Shih HI, Ko NY, Wang LR, et al. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect. 2006;39:135-143
21. Huang SS, Lee SC, Lee N, See LC, Tsai MH, Shieh WB. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections. J Microbiol Immunol Infect. 2007;40:134-140 (Pubitemid 46999320)
22. Patzer JA, Dzierzanowska D. Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002). Int J Antimicrob Agents. 2007;29:153-158
23. Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents. 2005;26:463-472
24. Chen S, Slavin M, Nguyen Q, Marriott D, Playford EG, Ellis D, et al. Australian Candidemia Study. Active surveillance for candidemia, Australia. Emerg Infect Dis. 2006;12:1508-1516
25. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel P. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;2:239-244 (Pubitemid 29380177)